Details
| Original language | English |
|---|---|
| Pages (from-to) | S21-S26 |
| Journal | European Journal of Health Economics |
| Volume | 10 |
| Issue number | SUPPL. 1 |
| Early online date | 10 Dec 2009 |
| Publication status | Published - Jan 2010 |
Abstract
This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
Keywords
- Cancer management, Colorectal cancer, CRC, Germany, Health policy
ASJC Scopus subject areas
- Economics, Econometrics and Finance(all)
- Economics, Econometrics and Finance (miscellaneous)
- Medicine(all)
- Health Policy
Sustainable Development Goals
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: European Journal of Health Economics, Vol. 10, No. SUPPL. 1, 01.2010, p. S21-S26.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Cancer management and reimbursement aspects in Germany
T2 - an overview demonstrated by the case of colorectal cancer
AU - Von Der Schulenburg, J. Matthias
AU - Prenzler, Anne
AU - Schurer, Willemien
PY - 2010/1
Y1 - 2010/1
N2 - This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
AB - This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.
KW - Cancer management
KW - Colorectal cancer
KW - CRC
KW - Germany
KW - Health policy
UR - http://www.scopus.com/inward/record.url?scp=76649126203&partnerID=8YFLogxK
U2 - 10.1007/s10198-009-0194-x
DO - 10.1007/s10198-009-0194-x
M3 - Article
AN - SCOPUS:76649126203
VL - 10
SP - S21-S26
JO - European Journal of Health Economics
JF - European Journal of Health Economics
SN - 1618-7598
IS - SUPPL. 1
ER -